500 related articles for article (PubMed ID: 18824350)
41. Synthesis and anti-HIV activity evaluation of 1-[(alkenyl or alkynyl or alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ji L; Chen FE; Xie B; De Clercq E; Balzarini J; Pannecouque C
Eur J Med Chem; 2007 Feb; 42(2):198-204. PubMed ID: 17095124
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis, anti-HIV activities, and metabolic stabilities of alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors.
Silvestri MA; Nagarajan M; De Clercq E; Pannecouque C; Cushman M
J Med Chem; 2004 Jun; 47(12):3149-62. PubMed ID: 15163195
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
[TBL] [Abstract][Full Text] [Related]
46. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
Su DS; Lim JJ; Tinney E; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Prasad S; Yan Y; Perlow-Poehnelt R; Torrent M; Miller M; Vacca JP; Williams TM; Anthony NJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):5119-23. PubMed ID: 19631528
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Liang YH; Feng XQ; Zeng ZS; Chen FE; Balzarini J; Pannecouque C; De Clercq E
ChemMedChem; 2009 Sep; 4(9):1537-45. PubMed ID: 19591191
[TBL] [Abstract][Full Text] [Related]
48. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and anti-HIV properties of novel 6-phenylselenenyl-5-propyluracils.
Miazga A; Felczak K; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
Acta Biochim Pol; 2007; 54(4):863-8. PubMed ID: 18066398
[TBL] [Abstract][Full Text] [Related]
51. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
[TBL] [Abstract][Full Text] [Related]
52. Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Spallarossa A; Cesarini S; Ranise A; Bruno O; Schenone S; La Colla P; Collu G; Sanna G; Secci B; Loddo R
Eur J Med Chem; 2009 Apr; 44(4):1650-63. PubMed ID: 18954921
[TBL] [Abstract][Full Text] [Related]
53. Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Boyer J; Arnoult E; Médebielle M; Guillemont J; Unge J; Jochmans D
J Med Chem; 2011 Dec; 54(23):7974-85. PubMed ID: 22017513
[TBL] [Abstract][Full Text] [Related]
54. [Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
Qin BJ; Zhou T; Lu H; Jiang SB; Xie L
Yao Xue Xue Bao; 2009 Nov; 44(11):1233-43. PubMed ID: 21355324
[TBL] [Abstract][Full Text] [Related]
55. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
[TBL] [Abstract][Full Text] [Related]
57. Arylazolylthioacetanilide. Part 11: design, synthesis and biological evaluation of 1,2,4-triazole thioacetanilide derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Li Z; Cao Y; Zhan P; Pannecouque C; Balzarini J; Clercq ED; Shen Y; Liu X
Med Chem; 2013 Nov; 9(7):968-73. PubMed ID: 23072552
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
Wang YP; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Eur J Med Chem; 2009 Mar; 44(3):1016-23. PubMed ID: 18692274
[TBL] [Abstract][Full Text] [Related]
59. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives.
Ranise A; Spallarossa A; Schenone S; Bruno O; Bondavalli F; Vargiu L; Marceddu T; Mura M; La Colla P; Pani A
J Med Chem; 2003 Feb; 46(5):768-81. PubMed ID: 12593657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
